Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by Redbaron2211on Feb 05, 2021 11:59pm
206 Views
Post# 32491834

RE:RE:busy times here...

RE:RE:busy times here...Sigilon may need Sernova but Sernova has successfully proven their own cells corrected for F8 can be replicated and scaled-up.   I haven't looked at Sigilon's coating spheres in detail but they are injected into the abdominin of the animals and seems to show some promise but all the data is preclinical not sure how they are collected and redosed it seems a little more complex and invasive then the cell pouch.  Sernova uses a human form of the F8 gene and inserts it into the animal cells with a virus vector.   Preclinical data with sernova is promising especially considering they are already using the human form of F8 gene.   
<< Previous
Bullboard Posts
Next >>